Corey Moore, Ph.D., utilizes his professional experience and technical background to provide clients with strategies to cultivate and safeguard their intellectual property and to provide solutions that help achieve their business goals. Corey’s practice focuses on creating and developing U.S. and international intellectual property rights that are aligned with client business objectives, including working closely with scientific personnel to identify patenting opportunities and competitive advantages.
Corey’s subject area focus is broadly in the life sciences, including cell-based therapies, antibodies, drug delivery, nucleic acids, immunotherapies, microbiome agents, gene-editing technologies, cultured foods, tissue engineering, and machine learning.
Corey, a Horatio Alger Scholar, received his Ph.D. from Purdue University. His doctoral research examined the structure-function of deubiquitinating enzymes in driving cellular transformation and using the mechanistic insights to identify and engineer pre-clinical drug leads. Throughout his graduate training, Corey was an instructor for biology, biochemistry, and microbiology courses at Purdue.
Corey is also an active member of the American Chemical Society (ACS), the American Institute of Biological Sciences (AIBS), and the Society for the Advancement of Chicanos/Hispanics & Native Americans in Science (SACNAS).
Member, American Institute of Biological Sciences
Member, Society for the Advancement of Chicanos/Hispanics & Native Americans in Science
Member, American Chemical Society
Andrews Fellow, Purdue University (2014–2016)
Horatio Alger Scholar (2009–2013)